![Mark Warne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Warne
Chief Executive Officer at
DEEPMATTER GROUP PLC
Net worth: 24 643 $ as of 2026-09-29
Profile
Dr. Mark R.
Warne is a Non-Executive Chairman at Ixico Plc, a Chief Executive Officer & Executive Director at ChemAI Ltd., an Advisor at Angelini Ventures SpA, a Healthcare Portfolio Director at IP Group Plc /Venture Capital/ and a Member at The Royal Society of Chemistry.
He is on the Board of Directors at hVIVO Services Ltd., ChemAI Ltd., DegraSense Ltd. and Genomics Ltd. Dr. Warne was previously employed as an Independent Non-Executive Director by Open Orphan Plc, a Non-Executive Director by hVIVO Holdings Ltd., a Head-Healthcare by IP Group Plc, a Non-Executive Director by Activiomics Ltd., a Non-Executive Director by Crysalin Ltd., a Non-Executive Director by Optimal Medicine Ltd., and a Managing Director by Receptor Research Ltd. He also served on the board at Azellon Ltd., Capsant Neurotechnologies Ltd., Iksuda Therapeutics Ltd. and Ubiquigent Ltd. He received his undergraduate degree from the University of Bristol, a graduate degree from the University of Bristol and a doctorate degree from the University of Bristol.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IXICO PLC 0.11% | 2026-07-14 | 247,341 ( 0.11% ) | 24 643 $ | 2026-09-29 |
Mark Warne active positions
| Companies | Position | Start |
|---|---|---|
| DEEPMATTER GROUP PLC | Chief Executive Officer | 2018-07-01 |
| IXICO PLC | Chairman | - |
Angelini Ventures SpA
 Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements. | Consultant / Advisor | - |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Director/Board Member | 2016-03-31 |
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology | Director/Board Member | - |
DegraSense Ltd. | Director/Board Member | - |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | 2011-03-15 |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Former positions of Mark Warne
| Companies | Position | End |
|---|---|---|
| HVIVO PLC | Director/Board Member | 2020-12-30 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Education of Mark Warne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
hVIVO Holdings Ltd.
 hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Ixico Plc
 Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
IP Group Plc
 IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company | Commercial Services |
Receptor Research Ltd.
 Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Provides drug discovery informatics products and services | Process Industries |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capsant Neurotechnologies Ltd.
 Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Provides pre-clinical assay services to the drug development industry | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions | Technology Services |
Azellon Ltd.
 Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapy for the repair of avascular meniscal tears | Commercial Services |
Crysalin Ltd.
 Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination | Health Technology |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Provides clinical development services for antibody-drug conjugate | Health Technology |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Commercial Services |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases | Technology Services |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements. | Finance |
DegraSense Ltd. | |
Ubiquigent Ltd.
 Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Develops reagents, kits, drug discovery assay development and compound profiling services | Commercial Services |
Optimal Medicine Ltd.
 Optimal Medicine Ltd. Packaged SoftwareTechnology Services Offers individualized clinical decision support software for mental health disorders | Technology Services |
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology | Health Technology |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
Angelini Ventures SpA
Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Mark Warne
